Post-Operative Follow-Up in Breast Cancer Using Tumor Markers
Author Information
Author(s): Nicolini Andrea, Tartarelli Gianna, Carpi Angelo, Metelli Maria Rita, Ferrari Paola, Anselmi Loretta, Conte Massimo, Berti Piero, Miccoli Paolo
Primary Institution: University of Pisa
Hypothesis
Can the CEA-TPA-CA15.3 panel improve early detection of distant metastases in breast cancer patients compared to MCA and MCA-CA15.3?
Conclusion
The CEA-TPA-CA15.3 panel is more accurate than the MCA-CA15.3 association for early detection of relapsed breast cancer patients.
Supporting Evidence
- MCA sensitivity was higher than that of CEA, TPA, or CA15.3.
- The CEA-TPA-CA15.3 panel detected 74% of recurrences.
- MCA specificity was lower than that of CEA and CA15.3.
Takeaway
Doctors can use certain blood tests to find out if breast cancer has come back after surgery, and some tests work better than others.
Methodology
The study compared the sensitivity and specificity of various tumor markers in 289 breast cancer patients during post-operative follow-up.
Potential Biases
Potential bias in the selection of tumor markers and patient demographics.
Limitations
The study's findings may not apply to all breast cancer patients due to the specific population studied.
Participant Demographics
Patients aged 27 to 80 years, with a median age of 51; 93% were disease-free at the start of the study.
Statistical Information
Statistical Significance
p n.s.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website